The impact of congenital heart disease on treatment and survival of patients with hepatoblastoma: A single‐center experience
Patients with HB and CHD have similar survival compared to those without CHD. Our data support that patients with HB and CHD should be treated with curative intent including cardiac surgical intervention, medical oncology therapy, and oncological surgery for their HB.
Authors
- Ashley Montgomery
- Andres F. Espinoza (ORCID: https://orcid.org/0000-0001-8716-3125)
- Jennifer H. Foster (ORCID: https://orcid.org/0000-0002-2126-9768)
- Andras Attila Heczey (ORCID: https://orcid.org/0000-0002-4263-9115)
- Sanjeev A. Vasudevan (ORCID: https://orcid.org/0000-0003-3578-4258)
- Heather A. Dickerson
- Nicholas C. Maamari
Institutions
- Baylor College of Medicine (US)
- Texas Children's Hospital (US)
- Children's Cancer Center (US)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2024-08-08
- DOI
- https://doi.org/10.1002/pbc.31214
- Citations
- 2
- Primary Topic
- Congenital Heart Disease Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.77
Funders
- Cancer Prevention and Research Institute of Texas
- Macy Easom Cancer Research Foundation